STRATEGIC PHARMA (Q2079217): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
(‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
label / frlabel / fr
 
PHARMACIE STRATÉGIQUE
Property / summary
 
PHARMACIE STRATÉGIQUE (French)
Property / summary: PHARMACIE STRATÉGIQUE (French) / rank
 
Normal rank
Property / summary: PHARMACIE STRATÉGIQUE (French) / qualifier
 
point in time: 18 December 2021
Timestamp+2021-12-18T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 14:57, 18 December 2021

Project Q2079217 in Italy
Language Label Description Also known as
English
STRATEGIC PHARMA
Project Q2079217 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    108,619.0 Euro
    0 references
    budget
    108,619.0 Euro
    0 references
    co-financing rate
    100.0 percent
    0 references
    start time
    31 August 2018
    0 references
    expected end time
    23 January 2020
    0 references
    beneficiary name (string)
    FONDAZIONE ITS - VITA - ITS PER LE NUOVE TECNOLOGIE DELLA VITA
    0 references
    beneficiary
    Q262905
    0 references
    programme
    Toscana - ESF
    0 references
    fund
    European Social Fund
    0 references
    coordinate location

    43°46'11.53"N, 11°15'20.09"E
    0 references
    summary
    STRATEGIC PHARMA (Italian)
    0 references
    STRATEGIC PHARMA (English)
    0 references
    PHARMACIE STRATÉGIQUE (French)
    point in time
    18 December 2021
    0 references

    Identifiers

    Italian Unique Project Code
    D17D18004530006
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2079217&oldid=20198636"